Valuation : QuidelOrtho Corporation

Market Cap 1.05B 905M 849M 775M 1.46B 100B 1.46B 10.07B 3.93B 50.69B 3.94B 3.86B 168B P/E 2026 *
-3.72x
P/E 2027 * -5.53x
Enterprise Value 3.76B 3.24B 3.04B 2.78B 5.23B 360B 5.25B 36.07B 14.07B 182B 14.13B 13.82B 602B EV / Sales 2026 *
1.48x
EV / Sales 2027 * 1.42x
Free-Float
99.11%
Yield 2026 *
-
Yield 2027 * -
1 day-2.68%
1 week+1.76%
Current month-10.55%
1 month-10.02%
3 months+14.77%
6 months-33.63%
Current year-47.48%
1 week 14.18
Extreme 14.175
15.5
1 month 11.41
Extreme 11.41
18.04
Current year 9.92
Extreme 9.92
35.58
1 year 9.92
Extreme 9.92
35.58
3 years 9.92
Extreme 9.92
84.6
5 years 9.92
Extreme 9.92
180.06
10 years 9.92
Extreme 9.92
306.72
Manager TitleAgeSince
Chief Executive Officer 61 06/05/2024
Director of Finance/CFO 48 06/07/2026
Chief Operating Officer 57 15/11/2024
Director TitleAgeSince
Chairman 72 11/12/2022
Director/Board Member 71 01/01/2022
Director/Board Member 82 01/01/1993
Date Insider Type Main position Quantity % Market Cap.
8/15/26 A Fiscal year

EVP Global Port. Mgmt & Mkting

1,054 0.0015%
7/15/26 A Free

Chief Financial Officer

356,555 0.5251%
7/6/26 A Other

Chief Financial Officer

0 0%
Change 5-day change 1-year change 3-year change Capi.($)
-2.55%+1.76%-46.43%-80.57% 1.05B
+1.24%+2.71%+29.01%-28.13% 17.96B
-0.71%-2.30%-25.51%+101.29% 1.66B
+0.61%-3.00%-24.26%+22.67% 959M
+0.08%-0.03%+61.33%-5.49% 779M
-3.02%-4.58%-35.97%-46.09% 693M
+0.18%-2.01%-42.83%-48.50% 565M
+0.67%+1.77%-37.71%-35.71% 461M
-3.15%0.00%+70.61%+46.91% 459M
-0.36%+0.37%-7.23%-8.78% 413M
Average -0.78%+2.94%-5.90%-8.24% 2.5B
Weighted average by Cap. +0.50%+1.52%+16.69%-18.48%

Financials

2026 *2027 *
Net sales 2.54B 2.19B 2.06B 1.88B 3.54B 243B 3.55B 24.39B 9.52B 123B 9.55B 9.35B 407B 2.59B 2.23B 2.09B 1.91B 3.6B 248B 3.61B 24.84B 9.69B 125B 9.73B 9.52B 415B
Net income -282M -243M -227M -208M -391M -26.91B -392M -2.7B -1.05B -13.58B -1.06B -1.03B -45.04B -190M -164M -154M -140M -264M -18.19B -265M -1.82B -712M -9.18B -714M -699M -30.44B
Net Debt 2.71B 2.34B 2.19B 2B 3.77B 259B 3.78B 26B 10.15B 131B 10.18B 9.96B 434B 2.62B 2.26B 2.12B 1.94B 3.65B 251B 3.66B 25.16B 9.81B 127B 9.85B 9.64B 420B
Logo QuidelOrtho Corporation
QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Optix and others.
Employees
6,500
Date Price Change Volume
28/08/26 $15.00 -2.09% 503,532
27/08/26 $15.32 +2.75% 816,144
26/08/26 $14.91 -0.93% 1,599,003
25/08/26 $15.05 +3.86% 987,350
24/08/26 $14.49 -1.70% 1,039,094
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
15.32USD
Average target price
14.67USD
Spread / Average Target
-4.26%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. QDEL Stock